Products for Research Use Only
RegisterLogin

Orticumab Biosimilar (oxLDL Reference Antibody)

CAT: 0013-GTR18594889-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR18594889-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL) . Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL) . Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement.
Target
Orticumab Biosimilar (Anti-oxLDL Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.

Related Products

CatalogName
GTR18315571OxLDL Reference Antibody (orticumab)
GTR18780241-01(Orticumab) Biosimilar Reference Antibody
GTR18117355Orticumab (oxLDL) - Research Grade Biosimilar Antibody
GTR18594890-01OxLDL Biosimilar (Okayama U. patent oxLDL Reference Antibody)
GTR18311416-01OxLDL Reference Antibody
GTR18337638-01Orticumab Antibody
GTR18153915-01Orticumab
GTR18781523-01(Galvokimig2) Biosimilar Reference Antibody
GTR18781412-01(Fremanezumab) Biosimilar Reference Antibody
GTR18781346-01(Fiztasovimab) Biosimilar Reference Antibody

Alternative Products

CatalogName
GS40515-01(Orticumab) Biosimilar Reference Antibody (OxLDL) (CAS NO:1314241-10-5)
E24CHA961Anti-oxLDL Reference Antibody (Okayama U. anti-oxLDL)
M34020Anti-oxLDL Reference Antibody (orticumab)
M34020-1Anti-oxLDL Reference Antibody (Okayama U. patent anti-oxLDL)
GS40827-01(Icatolimab) Biosimilar Reference Antibody (BTLA) (CAS NO:2236068-83-8)
GS40823-01(Zolbetuximab) Biosimilar Reference Antibody (CLDN18) (CAS NO:1496553-00-4)
GS40814-01(Zansecimab) Biosimilar Reference Antibody (ANGPT2) (CAS NO:2415205-37-5)
GS40813-01(Zanolimumab) Biosimilar Reference Antibody (CD4) (CAS NO:652153-01-0)
GS40806-01(Xeligekimab) Biosimilar Reference Antibody (IL17A) (CAS NO:2382921-73-3)
GS40799-01(Volociximab) Biosimilar Reference Antibody (ITGA5B1) (CAS NO:558480-40-3)

Popular Products